![](https://endpts.com/wp-content/uploads/2022/09/Brett-Monia-Ionis.jpg)
Brett Monia, Ionis CEO
Updated: Roche, Ionis launch new Huntington’s disease study
SAN FRANCISCO — A new study for the Huntington’s disease drug tominersen, developed in tandem by Roche and Ionis, “is open and has started screening eligible …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.